SCHEMBL7401084

SCHEMBL7401084

CCOC(=O)CCNC(=O)c1cc(OCCCN)no1

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SMPD1 P17405 2/20 0.50
POLB P06746 2/20 0.45
CYP1A2 P05177 2/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2C19 P33261 1/20 0.40
MAPT P10636 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.39
ALDH1A1 P00352 2/20 0.39
KDM4E B2RXH2 1/20 0.39
HPGD P15428 1/20 0.39
LMNA P02545 1/20 0.37
HTT P42858 1/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
LTA4H P09960 2/20 0.36
MCL1 Q07820 1/20 0.36
MLYCD O95822 1/20 0.36
SMYD3 Q9H7B4 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7401023 0.83 SMPD1 (0.45) SMPD1POLBCYP1A2CYP3A4CYP2C19
SCHEMBL7403157 0.82 SMPD1 (0.43) SMPD1POLBCYP1A2CYP3A4CYP2C19
SCHEMBL8532598 0.78 POLB (0.54) POLBCYP1A2CYP3A4CYP2C19MAPT
SCHEMBL8646113 0.77 SMPD1 (0.58) SMPD1POLBALDH1A1KDM4EKMT2A
SCHEMBL9819421 0.73 CYP3A4 (0.58) POLBCYP1A2CYP3A4CYP2C19MAPT
SCHEMBL8620461 0.72 CTSK (0.40) SMPD1POLBCYP1A2CYP3A4CYP2C19
SCHEMBL9819487 0.70 CYP3A4 (0.54) POLBCYP1A2CYP3A4CYP2C19MAPT
SCHEMBL12999414 0.68 POLB (0.45) POLBCYP1A2CYP3A4CYP2C19MAPT
SCHEMBL21467395 0.68 POLB (0.68) SMPD1POLBMAPTSMN1; SMN2ALDH1A1
SCHEMBL4124767 0.67 SMPD1 (0.44) SMPD1POLBSMN1; SMN2ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5710159-A IMIDAZOLIN-2-YLAMINOPROPOXY)ISOXAZOL-5-CARBONYLAMINO-2 -BENZYLOXYCARBONYLAMINOPROPIONIC ACID AS ANTIINFLAMMATORY AGENTS, BONE DEGRADATION, TUMORS, METASTASES AND THROMBOSIS THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) 1998-01-20 US disclosed
WO-1996037492-A1 ISOXAZOLINE AND ISOXAZOLE DERIVATIVES AS INTEGRIN RECEPTOR ANTAGONISTS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1996-11-28 WO disclosed